THE Health Department has
opened the public submission
process for its post-market reviews
of Chronic Obstructive Pulmonary
Disease (COPD) medicines as well
as Ezetimibe.
Both consultations will be open
for a seven week process, closing at
5pm eastern time on Fri 22 April.
The consultations aim to look at
the current use of the medications
in the light of clinical guidelines as
well as recent clinical studies that
look at long term patient outcomes.
For COPD medicines the terms
of reference aim to analyse
the utilisation of PBS listed
therapies to “identify the extent
of co-prescribing and use that is
inconsistent with clinical guidelines
and/or PBS restrictions”.
For details see www.pbs.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 09 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Mar 16
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.